Cargando…
A Retrospective Study of Clinical Response Predictors in Subcutaneous Allergen Immunotherapy With House Dust Mites for Allergic Rhinitis
PURPOSE: House dust mites (HDM) are major allergens that cause allergic rhinitis (AR). Allergen-specific subcutaneous immunotherapy (SCIT) has been shown to be clinically beneficial in many clinical trials. Such trials, however, are not reflective of all patient populations. The aim of this study wa...
Autores principales: | Lee, Ji-Ho, Kim, Su-Chin, Choi, Hyunna, Jung, Chang-Gyu, Ban, Ga-Young, Shin, Yoo Seob, Nahm, Dong-Ho, Park, Hae-Sim, Ye, Young-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705479/ https://www.ncbi.nlm.nih.gov/pubmed/29178674 http://dx.doi.org/10.4168/aair.2018.10.1.18 |
Ejemplares similares
-
Prevalence and Clinical Characteristics of Local Allergic Rhinitis to House Dust Mites
por: Jung, Chang-Gyu, et al.
Publicado: (2017) -
Safety of Ultra-rush Schedule of Subcutaneous Allergen Immunotherapy With House Dust Mite Extract Conducted in an Outpatient Clinic in Patients With Atopic Dermatitis and Allergic Rhinitis
por: Lee, So-Hee, et al.
Publicado: (2019) -
Efficacy and Safety of Sublingual Immunotherapy in Elderly Rhinitis Patients Sensitized to House Dust Mites
por: Kim, Ji Hye, et al.
Publicado: (2018) -
Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens
por: Trebuchon, Florence, et al.
Publicado: (2014) -
Subcutaneous Immunotherapy for Allergic Asthma in a Single Center of Korea: Efficacy, Safety, and Clinical Response Predictors
por: Lee, Ji-Ho, et al.
Publicado: (2017)